Evaluating urine volume and host depletion methods to enable genome-resolved metagenomics of the urobiome.

DNA extraction Microbiome Urine Urobiome canine genome-resolved metagenomics host depletion low biomass

Journal

Research square
ISSN: 2693-5015
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035

Informations de publication

Date de publication:
05 Aug 2024
Historique:
pubmed: 16 8 2024
medline: 16 8 2024
entrez: 16 8 2024
Statut: epublish

Résumé

The gut microbiome has emerged as a clear player in health and disease, in part by mediating host response to environment and lifestyle. The urobiome (microbiota of the urinary tract) likely functions similarly. However, efforts to characterize the urobiome and assess its functional potential have been limited due to technical challenges including low microbial biomass and high host cell shedding in urine. Here, to begin addressing these challenges, we evaluate urine sample volume (100 ml - 5 mL), and host DNA depletion methods and their effects on urobiome profiles in healthy dogs, which are a robust large animal model for the human urobiome. We collected urine from seven dogs and fractionated samples into aliquots. One set of samples was spiked with host (canine) cells to model a biologically relevant host cell burden in urine. Samples then underwent DNA extraction followed by 16S rRNA gene and shotgun metagenomic sequencing. We then assembled metagenome assembled genomes (MAGs) and compared microbial composition and diversity across groups. We tested six methods of DNA extraction: QIAamp BiOstic Bacteremia (no host depletion), QIAamp DNA Microbiome, Molzym MolYsis, NEBNext Microbiome DNA Enrichment, Zymo HostZERO, and Propidium Monoazide. In relation to urine sample volume, This is the first study, to our knowledge, to demonstrate environmental chemical degradation potential in urine microbes through genome-resolved metagenomics. These findings provide guidelines for studying the urobiome in relation to sample volume and host depletion, and lay the foundation for future evaluation of urobiome function in relation to health and disease.

Sections du résumé

Background UNASSIGNED
The gut microbiome has emerged as a clear player in health and disease, in part by mediating host response to environment and lifestyle. The urobiome (microbiota of the urinary tract) likely functions similarly. However, efforts to characterize the urobiome and assess its functional potential have been limited due to technical challenges including low microbial biomass and high host cell shedding in urine. Here, to begin addressing these challenges, we evaluate urine sample volume (100 ml - 5 mL), and host DNA depletion methods and their effects on urobiome profiles in healthy dogs, which are a robust large animal model for the human urobiome. We collected urine from seven dogs and fractionated samples into aliquots. One set of samples was spiked with host (canine) cells to model a biologically relevant host cell burden in urine. Samples then underwent DNA extraction followed by 16S rRNA gene and shotgun metagenomic sequencing. We then assembled metagenome assembled genomes (MAGs) and compared microbial composition and diversity across groups. We tested six methods of DNA extraction: QIAamp BiOstic Bacteremia (no host depletion), QIAamp DNA Microbiome, Molzym MolYsis, NEBNext Microbiome DNA Enrichment, Zymo HostZERO, and Propidium Monoazide.
Results UNASSIGNED
In relation to urine sample volume,
Conclusions UNASSIGNED
This is the first study, to our knowledge, to demonstrate environmental chemical degradation potential in urine microbes through genome-resolved metagenomics. These findings provide guidelines for studying the urobiome in relation to sample volume and host depletion, and lay the foundation for future evaluation of urobiome function in relation to health and disease.

Identifiants

pubmed: 39149494
doi: 10.21203/rs.3.rs-4688526/v1
pmc: PMC11326377
pii:
doi:

Types de publication

Journal Article Preprint

Langues

eng

Subventions

Organisme : NIEHS NIH HHS
ID : K08 ES034821
Pays : United States

Déclaration de conflit d'intérêts

Competing Interests The authors declare that they have no competing interests.

Références

Curr Oncol Rep. 2024 Mar;26(3):292-298
pubmed: 38376627
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
J Clin Med. 2021 Mar 05;10(5):
pubmed: 33807946
Pathog Dis. 2016 Oct;74(7):
pubmed: 27402784
Microbiol Rev. 1989 Mar;53(1):85-108
pubmed: 2651866
mSphere. 2024 Jan 30;9(1):e0047023
pubmed: 38054728
J Vet Intern Med. 2023 Nov-Dec;37(6):2219-2229
pubmed: 37682015
PeerJ. 2019 Jul 26;7:e7359
pubmed: 31388474
Clin Microbiol Rev. 2010 Apr;23(2):382-98
pubmed: 20375358
Infect Immun. 2000 Jun;68(6):3327-36
pubmed: 10816481
J Clin Microbiol. 2008 Dec;46(12):4078-82
pubmed: 18945846
Front Oncol. 2020 Jan 21;9:1493
pubmed: 32039002
Bioinformatics. 2015 May 15;31(10):1674-6
pubmed: 25609793
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Microbiome. 2022 Jan 17;10(1):6
pubmed: 35039079
Bioinformatics. 2016 Feb 15;32(4):605-7
pubmed: 26515820
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
FEMS Microbiol Ecol. 2014 Apr;88(1):129-39
pubmed: 24372170
Nat Clin Pract Urol. 2006 Jun;3(6):327-40
pubmed: 16763645
Nat Methods. 2023 Nov;20(11):1672-1682
pubmed: 37828152
Nat Methods. 2014 Nov;11(11):1144-6
pubmed: 25218180
ISME J. 2017 Dec;11(12):2864-2868
pubmed: 28742071
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W29-37
pubmed: 21593126
Environ Health Perspect. 2005 Jan;113(1):6-10
pubmed: 15626640
Nucleic Acids Res. 2020 Sep 18;48(16):8883-8900
pubmed: 32766782
Microbiome. 2018 Feb 27;6(1):42
pubmed: 29482639
mBio. 2023 Dec 19;14(6):e0251523
pubmed: 37962362
Arch Toxicol. 2017 Jun;91(6):2331-2341
pubmed: 28378121
Microbiology (Reading). 2002 Jan;148(Pt 1):257-266
pubmed: 11782518
Sci Rep. 2022 Mar 7;12(1):4000
pubmed: 35256725
Urolithiasis. 2016 Oct;44(5):399-407
pubmed: 27115405
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Nat Microbiol. 2022 May;7(5):630-639
pubmed: 35505248
J Clin Microbiol. 2014 Mar;52(3):871-6
pubmed: 24371246
Nat Biotechnol. 2023 Nov;41(11):1633-1644
pubmed: 36823356
mBio. 2014 Jul 08;5(4):e01283-14
pubmed: 25006228
Vet Pathol. 2020 Mar;57(2):227-240
pubmed: 32081094
Sci Rep. 2021 Mar 17;11(1):6186
pubmed: 33731788
Vet J. 2024 Feb;303:106044
pubmed: 38000695
Sci Rep. 2022 May 19;12(1):8470
pubmed: 35589762
Genome Biol. 2024 Mar 21;25(1):75
pubmed: 38515176
Urolithiasis. 2022 Jun;50(3):303-317
pubmed: 35234986
mSystems. 2019 Jun 4;4(4):
pubmed: 31164452
PLoS One. 2021 Jul 9;16(7):e0253989
pubmed: 34242284
Nat Rev Urol. 2018 Dec;15(12):735-749
pubmed: 30315209
Microbiol Spectr. 2022 Apr 27;10(2):e0041221
pubmed: 35404108
Eur Urol Oncol. 2023 Apr;6(2):190-203
pubmed: 36868921
Front Genet. 2023 Apr 26;14:1184473
pubmed: 37180976
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Genome Res. 2015 Jul;25(7):1043-55
pubmed: 25977477
Arch Microbiol. 1999 May-Jun;171(6):430-8
pubmed: 10369899
mBio. 2020 Apr 21;11(2):
pubmed: 32317321
Microbiol Spectr. 2016 Oct;4(5):
pubmed: 27780014
Microbiome. 2021 Oct 12;9(1):202
pubmed: 34641955
Br J Cancer. 2022 Jun;126(10):1499-1507
pubmed: 35173304
J Environ Sci (China). 2022 Apr;114:37-52
pubmed: 35459500
Trends Microbiol. 2019 Feb;27(2):105-117
pubmed: 30497919
Sci Rep. 2018 Mar 12;8(1):4333
pubmed: 29531289
Biol Proced Online. 2022 Dec 1;24(1):20
pubmed: 36456991
Sci Rep. 2020 Oct 1;10(1):16356
pubmed: 33004967
Front Microbiol. 2022 Jan 07;12:764058
pubmed: 35069469
Bioinformatics. 2019 Nov 15;:
pubmed: 31730192
Sci Total Environ. 2022 Mar 1;810:151187
pubmed: 34756911
J Vet Intern Med. 2022 Jul;36(4):1341-1352
pubmed: 35796316
iScience. 2021 Oct 16;24(11):103306
pubmed: 34765924
Environ Microbiome. 2023 Apr 30;18(1):39
pubmed: 37122013
Vet Microbiol. 2019 Jan;228:77-82
pubmed: 30593384
Sci Adv. 2023 Nov 10;9(45):eadi9834
pubmed: 37939183
Nat Rev Microbiol. 2018 Jul;16(7):410-422
pubmed: 29795328
Microbiome. 2018 Sep 15;6(1):158
pubmed: 30219103
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
PLoS One. 2013 Sep 04;8(9):e73076
pubmed: 24023812

Auteurs

Zachary J Lewis (ZJ)

Department of Veterinary Preventive Medicine, The Ohio State University.

Angela Scott (A)

Department of Veterinary Preventive Medicine, The Ohio State University.

Christopher Madden (C)

Department of Veterinary Preventive Medicine, The Ohio State University.

Dean Vik (D)

Center of Microbiome Science, The Ohio State University.

Ahmed A Zayed (AA)

Department of Microbiology, The Ohio State University.

Garrett J Smith (GJ)

Center of Microbiome Science, The Ohio State University.

Sheryl S Justice (SS)

College of Nursing, The Ohio State University.

Adam Rudinsky (A)

Department of Veterinary Clinical Sciences, The Ohio State University.

Jessica Hokamp (J)

Department of Veterinary Biosciences, The Ohio State University.

Vanessa L Hale (VL)

Department of Veterinary Preventive Medicine, The Ohio State University.

Classifications MeSH